Two Fatal Cases of Hepatitis B Virus Carriers after Corticosteroid Therapy for Bronchial Asthma

18Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We report two hepatitis B virus (HBV) carriers who had liver failure after withdrawal of corticosteroids (steroids) administered for treatment of serious asthmatic attacks. Liver functions deteriorated 1 to 2wk after withdrawal of the steroid therapy and liver failure occurred. Steroid readministration and intensive therapy for liver failure did not prevent death. An excessive immune response provoked by steroid withdrawal and decreased reserve capacity due to underlying chronic liver disease were thought to be factors in the liver failure. Caution must be exercised in the administration of steroids to patients with underlying chronic HBV infection to prevent exacerbation of hepatitis. Prompt readministration of steroids is indicated if evidence of liver failure develops. © 1992, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Koga, Y., Kumashiro, R., Yasumoto, K., Shakado, S., Ono, N., Noguchi, H., … Tanikawa, K. (1992). Two Fatal Cases of Hepatitis B Virus Carriers after Corticosteroid Therapy for Bronchial Asthma. Internal Medicine, 31(2), 208–213. https://doi.org/10.2169/internalmedicine.31.208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free